Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Hodak

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Cancer Cytopathology|January 26, 2010
Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance"N Paul Ohori, Marina N Nikiforova, Karen E Schoedel, et al.
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Surgery|December 5, 2009
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationLinwah Yip, Marina N Nikiforova, Sally E Carty, et al.
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 18, 2017
NONINVASIVE FOLLICULAR TUMOR WITH PAPILLARY-LIKE NUCLEAR FEATURES: NOT A TEMPEST IN A TEAPOTNidhi Agrawal, Collette E Abbott, Cheng Liu, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Cancer Cytopathology|August 19, 2014
Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristicsLisa A Radkay, Simion I Chiosea, Raja R Seethala, et al.
Thyroid : Official Journal of the American Thyroid Association|January 24, 2025
<i>Letter to the Editor:</i> New Current Procedural Terminology Codes for Radiofrequency Ablation of Thyroid Nodules Will Negatively Affect American Patients According to the Executive Council of the North American Society for Interventional ThyroidologyJonathon O Russell, Timothy Huber, Julia Noel, et al.
Thyroid : Official Journal of the American Thyroid Association|June 11, 2015
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision MakingRobert L Ferris, Zubair Baloch, Victor Bernet, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cancer Cytopathology|January 26, 2010
Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance"N Paul Ohori, Marina N Nikiforova, Karen E Schoedel, et al.
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Surgery|December 5, 2009
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationLinwah Yip, Marina N Nikiforova, Sally E Carty, et al.
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 18, 2017
NONINVASIVE FOLLICULAR TUMOR WITH PAPILLARY-LIKE NUCLEAR FEATURES: NOT A TEMPEST IN A TEAPOTNidhi Agrawal, Collette E Abbott, Cheng Liu, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Cancer Cytopathology|August 19, 2014
Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristicsLisa A Radkay, Simion I Chiosea, Raja R Seethala, et al.
Thyroid : Official Journal of the American Thyroid Association|January 24, 2025
<i>Letter to the Editor:</i> New Current Procedural Terminology Codes for Radiofrequency Ablation of Thyroid Nodules Will Negatively Affect American Patients According to the Executive Council of the North American Society for Interventional ThyroidologyJonathon O Russell, Timothy Huber, Julia Noel, et al.
Thyroid : Official Journal of the American Thyroid Association|June 11, 2015
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision MakingRobert L Ferris, Zubair Baloch, Victor Bernet, et al.
Pageof 6